Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Fri, 04th Jul 2014 16:30

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or 45.5p. He disposed of a total of 1.85m shares, leaving him with 64.33m, equivalent to 18.23% of the issued share capital. Top Director BuysSTM Group (STM) Director name: Mr Alan Roy KentishAmount purchased: 1,666,667 @ 18.00p Value: £300,000Frontier Developments (FDEV) Director name: Mr David Ranken GammonAmount purchased: 20,000 @ 230.00p Value: £46,000STM Group (STM) Director name: Mr Therese NeishAmount purchased: 250,000 @ 18.00p Value: £45,000Accesso Technology Group (ACSO) Director name: Mr David Ranken GammonAmount purchased: 7,500 @ 510.00p Value: £38,250STM Group (STM) Director name: Mr Colin PorterAmount purchased: 200,000 @ 18.00p Value: £36,000Frontier Developments (FDEV) Director name: Mr David John Braben Amount purchased: 15,000 @ 230.00p Value: £34,500Mercantile Investment Trust (The) (MRC) Director name: Mr Harry MorleyAmount purchased: 2,000 @ 1,485.20p Value: £29,704e-Therapeutics (ETX) Director name: Mr Steve MedlicottAmount purchased: 100,000 @ 29.00p Value: £29,000STM Group (STM) Director name: Mr Julian TellingAmount purchased: 138,889 @ 18.00p Value: £25,000Harvey Nash Group (HVN) Director name: Mr Albert EllisAmount purchased: 17,294 @ 110.00p Value: £19,023Top Director SellsDaily Mail and General Trust A (Non.V) (DMGT) Director name: The Viscount RothermereAmount sold: 1,850,000 @ 860.00p Value: £15,910,000Hargreaves Lansdown (HL.) Director name: Ms Tracey TaylorAmount sold: 70,682 @ 1,272.00p Value: £899,075Hargreaves Lansdown (HL.) Director name: Ms Tracey TaylorAmount sold: 32,687 @ 1,275.00p Value: £416,759Hargreaves Lansdown (HL.) Director name: Mr Dharmash MistryAmount sold: 5,308 @ 1,267.00p Value: £67,252NR
More News
29 Jun 2010 16:00

UK SMALLCAP ROUNDUP: E-Therapeutics Seeks Pharma Alliances

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps E-THERAPEUTICS PLC (ETX.LN), a U.K. drug developer, said Tuesday its focus this year and next will be on clinical trials of its experimental medicines an

Read more
29 Jun 2010 12:06

INTERVIEW: E-Therapeutics Readies Trials, Seeks Alliances

By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--U.K. drug developer e-Therapeutics PLC (ETX.LN) Tuesday said its focus this year and next will be on clinical trials of its experimental medicines and securing alliances with pharmaceutical companies. E-Therapeutics, which uses

Read more
29 Jun 2010 11:03

Small caps round-up: Northern Bear, Airsprung, Pursuit Dynamics...

Support services group Northern Bear stretched its strong run Tuesday after claiming a good start to the new financial year, with its order book and pipeline well up on a year ago. "The board is pleased to announce that the new financial year has started well, with strong order books and a healthy

Read more
29 Jun 2010 08:01

E-Therapeutics Loss Widens; In Talks With Drug Makers

LONDON (Dow Jones)--Drug discovery company e-Therapeutics PLC (ETX.LN) Tuesday reported a wider fiscal-year loss and said it remains in talks with drug makers about commercial collaborations. E-Therapeutics, which uses computer software to develop new drugs, added the first of several planned Ph

Read more
2 Mar 2010 16:33

Chairman's wife buys Redrow shares

Redrow chairman Steve Morgan's wife has bought 100,000 shares in the housebuilder taking their combined stake to 29.95%. Fiona Morgan paid 131.5p a share for the 100,000 shares. The total cost was £131,500. Morgan founded Redrow in 1974 and floated the company 20 years later. He also owns Wolver

Read more
27 Jul 2009 08:38

e-Therapeutics narrows losses

Drug discovery and development company e-Therapeutics said annual losses narrowed and it remains confident of becoming cash generative. For the year ended 31 January loss before tax narrowed to £1.96m from a loss of £2.2m the year before. Revenue increased to £67,000 from £64,000 the previous year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.